$2.550
-0.020
(-0.78%)
Delayed prices. Updated at 08 Sep 2026 17:04.
2.560
Open Price
2.570
Previous Close Price
3,417.480
Market Cap (M)
2.480 - 3.750 (51.21%)
52 Weeks Range
133.3
Volume (K)

About the Company

Sector & Industry Health Technology | Pharmaceuticals: Major
Category Classification China / Medical & Biotechnology
Under CPF Investment Scheme (CPFIS) No
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. is engaged in the research, development, processing, wholesale, retail, and manufacturing of Chinese herbal medicines, Chinese patent medicines, Chinese medicine decoction tablets, western medicine preparations, and other medical and health products. It operates through the Chinese Medicine & Western Medicine segments. The Chinese Medicine segment is involved in manufacturing of Chinese pharmaceutical products which are under brands owned by the Group. The Western Medicine segment includes manufacturing of western pharmaceutical products through cooperation with foreign companies. The company was founded on December 20, 1992 and is headquartered in Tianjin, China.

Loading Chart...

Please login to view stock data and analysis
Please login to view stock data and analysis